MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$4,028K
Free Cash flow
-$4,467K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Share-based compensation expense
    • Proceeds from exercise of pre-fu...
    • Trade and other payables
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Prepaid and other assets
    • Trade and other receivables
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Unrealized loss on investment
NaN NaN NaN 0
Net loss
-11,935 -11,837 -8,965 -37,917
Depreciation and amortization
14 14 13 66
Amortization of right-of-use assets
105 106 105 330
Gain on extinguishment of liabilities
0 0 NaN 764
Share-based compensation expense
7,592 7,379 5,180 17,426
Trade and other receivables
123 -123 -30 -197
Prepaid and other assets
454 195 -156 111
Trade and other payables
401 701 125 -2,378
Accrued employee benefits
59 19 37 -81
Lease liabilities
-111 -86 -32 -356
Net cash used in operating activities
-4,452 -3,776 -3,351 -23,588
Purchase of property and equipment
15 11 NaN 18
Net cash used in investing activities
-15 -11 0 -18
Proceeds from issuance of common stock, pre-funded warrants, and common warrants
NaN NaN NaN 30,460
Proceeds from the issuance of common stock
0 104,495 NaN NaN
Proceeds from exercise of pre-funded warrants, series 2 warrants and common warrants
507 0 0 42,344
Share issuance transaction costs
1 6,265 NaN 2,319
Net cash provided by financing activities
506 98,230 0 70,485
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
-67 -132 86 49
Net increase in cash, cash equivalents, and restricted cash
-4,028 94,311 -3,265 46,928
Cash, cash equivalents, and restricted cash, beginning of period
188,903 94,592 97,857 50,929
Cash, cash equivalents, and restricted cash, end of period
184,875 188,903 94,592 97,857
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from exercise ofpre-funded warrants,...$507K Net cash provided byfinancing activities$506K Canceled cashflow$1K Net increase incash, cash...-$4,028K Canceled cashflow$506K Share-based compensationexpense$7,592K Trade and otherpayables$401K Amortization of right-of-useassets$105K Accrued employeebenefits$59K Depreciation andamortization$14K Share issuancetransaction costs$1K Net cash used inoperating activities-$4,452K Canceled cashflow$8,171K Effects of exchange ratechanges on cash, cash...-$67K Net cash used ininvesting activities-$15K Net loss-$11,935K Prepaid and other assets$454K Trade and otherreceivables$123K Lease liabilities-$111K Purchase of property andequipment$15K

Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Inc. (BNTC)